Total Funding
85
68
Total FundingGrant raised
Growth Score
-10 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
15820
RareCyte provides biology solutions that deliver platforms and services in both spatial biology and liquid biopsy.
Joseph Victor: President & CEOPast Role: Purigen Biosystems, Executive Chairman
Stephen D. Reichenbach: Chief Financial OfficerPast Role: Applied Precision, Inc., Chief Financial Officer
About the Company
RareCyte is a provider of precision biology solutions that delivers platforms and services in both spatial biology and liquid biopsy. It offers tissue-based imaging tools under the Orion Spatial Biology suite, including imaging instruments and panels enabling multiplexed biomarker analysis in a single scan, and supplies rare cell analysis
instruments and consumables such as the CyteFinder II imaging systems, CytePicker module, AccuCyte sample preparation, and RarePlex panel kits for circulating tumor cell (CTC) detection and characterization. Additionally, RareCyte extends its offering with precision biology services encompassing custom assay development, clinical trial sample testing, and data analysis.
